Q3: 2025-11-13 Earnings Summary
EPS of -$0.10 misses by $0.01
| Revenue of $0.00 beats by $0.00
AirJoule Technologies Corporation (AIRJ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST
Company Participants
Tom Divine – Vice President of Investor Relations & Finance
Matthew Jore – CEO & Director
Patrick C. Eilers – Executive Chairman
Bryan Barton – Chief Commercialization Officer
Sze-Yin Pang – Chief Financial Officer
Conference Call Participants
Amit Dayal – H.C. Wainwright & Co, LLC, Research Division
Jacob Sekelsky – Alliance Global Partners, Research Division
Ryan Pfingst – B. Riley Securities, Inc., Research Division
Sean Milligan – Needham & Company, LLC, Research Division
George Gianarikas – Canaccord Genuity Corp., Research Division
Presentation
Operator
Greetings. Welcome to the AirJoule Technologies Third Quarter 2025 Earnings Call. [Operator Instructions]. Please note, this conference is being recorded. It is now my pleasure to turn the conference over to your host, Tom Divine, Vice President of Investor Relations and Finance. Thank you. You may begin.
Tom Divine
Vice President of Investor Relations & Finance
Thank you, and good morning. With me today for our third quarter earnings call are Matt Jore, Chief Executive Officer; Pat Eilers, Executive Chairman; Bryan Barton, Chief Commercialization Officer; and Stephen Pang, Chief Financial Officer. During this call, we’ll be referring to a presentation, which is available on the webcast platform and on the Investors section of our website. I would like to point out that many of the comments made during the prepared remarks and during the Q&A section are forward-looking statements that involve risks and uncertainties that could affect our actual results and plans.
Many of these risks are beyond our control and are discussed in more detail in the Risk Factors and the forward-looking statements sections of our filings with the SEC. Although we believe the expectations expressed are based on reasonable assumptions, they are not guarantees of future performance, and actual results or developments may differ materially. And now I’ll turn
